NEI Psychopharm

It’s Saturday morning. ☀️ Log in now to join Drs. Jeffrey Strawn and Karl Doghramji as they explore the intersection of sleep regulation and wellness in mental health care. Not registered yet? There’s still time. Registration is free but required: nei.global/26smlapr18

Posttraumatic stress disorder (PTSD) remains a chronic, often disabling condition, and current first-line treatments like SSRIs can fall short with slow onset and limited efficacy. A novel agent, TSND-201 (methylone), is drawing attention as a potential rapid-acting option. Read more nei.global/21151

Join us this Saturday, April 18, for a free half-day CME/CE program on sleep and mental health. Learn to identify and treat hypersomnia, narcolepsy, and insomnia, and gain practical strategies to improve patient outcomes.Save your spot today ➡️ nei.global/26sml-april18

This is it. Your final opportunity to lock in savings for the 2026 NEI Spring Congress. Join us in person or online and gain practical psychopharmacology strategies you can use right away to manage complex cases with greater confidence. nei.global/26spring-savin…

Long-acting injectable (LAI) antipsychotics remain underutilized, despite clear advantages over oral formulations. Explore a special collection featuring six CME articles on real-world LAI use, including early intervention, switching strategies, and practical prescribing insights. nei.global/cnsspectrums20…

Adolescent major depressive disorder is common and closely linked to suicide risk, with teens facing about a fivefold higher risk of attempts and up to 80% meeting criteria for depression at the time. Current treatments can take weeks to work, creating an urgent need for faster options. A recent study evaluated esketamine nasal spray, a rapid-acting NMDA receptor antagonist, in adolescents at imminent suicide risk. Read more: nei.global/21146

In this episode, Dr. Andy Cutler speaks with Dr. Holly Swartz about the critical role of sleep and circadian rhythms in bipolar disorder, including how sleep disturbance can function as both a symptom and trigger of mood episodes. Tune in now: nei.global/e279

What if we’re waiting too long to use clozapine in first-episode psychosis? Current treatment algorithms typically reserve clozapine until after two failed antipsychotic trials. But response rates drop with each step. A recent study explores whether introducing clozapine after just one failed trial could lead to better outcomes in patients ages 16–45 with first-episode psychosis. Is it time to rethink the algorithm? Read more: nei.global/21145

March 30 marks World Bipolar Day, a global effort to raise awareness of bipolar disorder and reduce stigma. At NEI, we support clinicians with evidence-based education designed to improve patient care. In recognition of the day, we are sharing resources on bipolar disorder to support your practice and enhance patient understanding. Explore expert insights, practical tools, and clinical guidance to help you better assess, diagnose, and manage bipolar disorder ➡️ nei.global/21144

#WorldBipolarDay is an important opportunity to raise awareness and address the stigma that continues to impact patients living with bipolar disorder. If you are looking for ways to improve conversations with your patients and support better long-term outcomes, we encourage you to watch the full session, found here: nei.global/enc25-25cngfa-…

On #NationalDoctorsDay, everyone at the Neuroscience Education Institute extends our sincere gratitude for the dedication and care you bring to patients living with mental illness. It is a privilege to support you in the important work you do every day. #ThankYouDoctors

Opening rates for 2026 NEI Fall Congress end on Tuesday, March 31st. Join us in Colorado or online via simulcast and stay current with the latest in psychopharmacology and mental health care! Learn from leading experts and gain practical, evidence-based strategies you can apply right away. Secure your spot today ➡️ nei.global/26fall-opening

Listen Now! 🎧 Dr. Robyn Thom discusses autism spectrum disorder (ASD), covering diagnosis, core features, and common psychiatric comorbidities. She shares practical tips for evaluating agitation, sorting overlapping symptoms, and choosing behavioral and medication strategies to support patients across the lifespan. nei.global/e278

The FDA has expanded approval of flibanserin to include postmenopausal women under age 65 with hypoactive sexual desire disorder (HSDD). This is a significant milestone in women’s health, marking the first oral treatment option for low sexual desire available to postmenopausal patients. Read more nei.global/21142

How do you turn complex #neuroscience into something clinicians can actually use? From dynamic visuals to real-world clinical insights, NEI’s approach to #psychopharmacology more accessible through visual, practical education designed for real-world clinical decision-making.

Happy #MatchDay! Congratulations to all the medical students who matched into #psychiatry. We newly matched residents complimentary access to NEI's member-only online psychopharmacology resources for six months. Claim Now : nei.global/match2026 #Match2026 #PsychiatryMatch

What is Match Day? What types of resources does @Inside_TheMatch provide for match applicants? In this classic NEI Podcast episode, Dr. Simone Bernstein addresses these questions and much more! Listen now nei.global/e176

What if depression treatment could be guided by biology, not just symptoms? Emerging research in neuroinflammation and insulin resistance is reshaping how we understand mood disorders and opening the door to more targeted, effective care. Explore how immunometabolic insights may transform clinical trials and treatment strategies. Read more: nei.global/21140

We're celebrating #BrainAwarenessWeek🧠 This initiative promotes awareness of neuroscience research and the incredible science behind the brain. Explore insights on how our growing understanding of the brain continues to shape mental health care. nei.global/21138

Early psychosis is a critical window for long term outcomes. On today's episode of the NEI Podcast, Dr. Andy Cutler talks with Dr. Robert Cotes about reducing duration of untreated psychosis, measuring more than symptom improvement, and engaging young adults and families in coordinated specialty care. Tune in for practical strategies to support lasting recovery. nei.global/e277